Potential applications of lactic acid bacteria and bacteriocins in anti-mycobacterial therapy

Journal Title: Asian Pacific Journal of Tropical Medicine - Year 2018, Vol 11, Issue 8

Abstract

Tuberculosis (TB) is a communicable disease caused by Mycobacterium tuberculosis (M. tuberculosis). WHO estimated that 10.4 million new (incident) TB cases worldwide in year 2016. The increased prevalence of drug resistant strains and side effects associated with the current anti-tubercular drugs make the treatment options more complicated. Hence, there are necessities to identify new drug candidates to fight against various sub-populations of M. tuberculosis with less or no toxicity/side effects and shorter treatment duration. Bacteriocins produced by lactic acid bacteria (LAB) attract attention of researchers because of its “Generally recognized as safe” status. LAB and its bacteriocins possess an effective antimicrobial activity against various bacteria and fungi. Interestingly bacteriocins such as nisin and lacticin 3147 have shown antimycobacterial activity in vitro. As probiotics, LAB plays a vital role in promoting various health benefits including ability to modulate immune response against various infectious diseases. LAB and its metabolic products activate immune system and thereby limiting the M. tuberculosis pathogenesis. The protein and peptide engineering techniques paved the ways to obtain hybrid bacteriocin derivatives from the known peptide sequence of existing bacteriocin. In this review, we focus on the antimycobacterial property and immunomodulatory role of LAB and its metabolic products. Techniques for large scale synthesis of potential bacteriocin with multifunctional activity and enhanced stability are also discussed.

Authors and Affiliations

Anbarasu Sivaraj

Keywords

Related Articles

Molecular and serological prevalence of Toxoplasma gondii in pregnant women and sheep in Egypt

Objective To investigate molecular and serological prevalence of Toxoplasma gondii (T. gondii) in pregnant women and sheep in Egypt. Methods Blood samples collected from healthy 364 pregnant women and 170 sheep were in...

Lipase inhibitory activity of Lagenaria siceraria fruit as a strategy to treat obesity

Objective: To explore pancreatic lipase inhibitory activity under different extraction conditions in order to track the most potent extract. Methods: The methanolic extract and its fractions in solvents of increasing pol...

A hiddenly high hepatitis C virus related liver disease burden among Chinese patients with non-liver disease complaints: A hospital based study from 2013 to 2017

Objective: To determine the frequency of anti-HCV antibody positivity in patients with nonliver disease complaints, to explore whether anti-HCV positive patients had been properly advised and visited hepatologists for fu...

Measles outbreaks in the Kyeongin area of the Republic of Korea, 2013–2014: A single-center experience in a country of measles elimination

Objective: To identify the source of infection and determine the clinical features and laboratory finding of measles infection. Methods: In 27 measles patients, except for 3 adult patients, the rest of 24 pediatric measl...

Occurrence of Chlamydia spp. in wild birds in Thailand

Objective: To determine the occurrence of Chlamydia spp. in wild birds in Thailand. Methods: Cloacal and tracheal swabs of 313 wild birds from 11 orders, 27 families, and 51 species were tested to determine the occurrenc...

Download PDF file
  • EP ID EP376173
  • DOI 10.4103/1995-7645.240080
  • Views 39
  • Downloads 0

How To Cite

Anbarasu Sivaraj (2018). Potential applications of lactic acid bacteria and bacteriocins in anti-mycobacterial therapy. Asian Pacific Journal of Tropical Medicine, 11(8), 453-459. https://europub.co.uk/articles/-A-376173